FDA Guides On Rivals To Primatene Mist And Spiriva Respimat
Agency Releases Batch Of 34 Product-Specific Guidances
A batch of almost three dozen new and revised product-specific guidances for generic products has been published by the US Food and Drug Administration, including for rivals to Primatene Mist (epinephrine) metered-dose inhaler and Spiriva Respimat (tiotropium bromide) inhalation spray.
